Clinical Trials in San Francisco

Showing 5721-5740 of 9,883 trials

Immunologic Response to Secukinumab in Plaque Psoriasis

NCT02592018

This is a single-arm, open-label study, which will examine the effect of secukinumab on the immunologic and genetic environment within psoriatic lesions.

Psoriasis

University of California, San Francisco15 participantsStarted Oct 2016

San Francisco, California, United States

COMPLETEDNA< 1 mile

Oral Iron for Erythropoietic Protoporphyrias

NCT02979249

In the medical literature there are conflicting reports on whether iron improves symptoms in patients with EPP and XLP. Giving iron to people who are iron deficient is thought to improve EPP symptoms. However, this has never been systematically tested. Therefore, the purpose of this study is to determine the effect of oral iron for EPP and XLP patients.

Erythropoietic ProtoporphyriaEPPX-linked Protoporphyria+1 more

Icahn School of Medicine at Mount Sinai16 participantsStarted Dec 2016

Birmingham, Alabama, United States • San Francisco, California, United States • New York, New York, United States +3 more locations

COMPLETEDPhase 2< 1 mile

A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT03160898

The purpose of this study was to assess the effect of CK-2127107 (hereafter referred to as reldesemtiv) versus placebo on respiratory function and other measures of skeletal muscle function in patients with ALS.

Amyotrophic Lateral Sclerosis

Cytokinetics458 participantsStarted Jul 2017

Phoenix, Arizona, United States • Los Angeles, California, United States • Orange, California, United States +61 more locations

Immunologic Response to Secukinumab in Plaque Psoriasis

Oral Iron for Erythropoietic Protoporphyrias

A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)

Find Trials by Condition in San Francisco

Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer

Safety and Efficacy Study of Single Weekly Bortezomib in Newly Diagnosed Multiple Myeloma

Renal AL Amyloid Involvement and NEOD001

Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year

A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19

18F-AV-1451 Autopsy Study

ALCMI-006: A Prospective Biospecimen Collection Study From Patients With ROS1-Fusion Positive Tumors

Safety and Efficacy Study of EPI-743 in Children With Leigh Syndrome

Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma

Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer

Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure

Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis

Safety and Efficacy of Pimavanserin in Adults With Parkinson's Disease and Depression

Study of Rapastinel as Monotherapy in Patients With MDD

Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke

ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer

An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids